Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy

A Antinori; M Borderi; Roberto Cauda; T Bini; A Chirianni; N Squillace; D Mancusi; R. Termini

doi:10.7448/IAS.17.4.19573

Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy

A Antinori
, M Borderi
, Roberto Cauda
, T Bini
, A Chirianni
, N Squillace
, D Mancusi
, R. Termini

Research output: Contribution to journal › Article

Abstract

This descriptive, non-interventional study on HIV-1-infected patients treated with DRV/r in the usual clinical setting, with a single-arm prospective observational design, collected data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in marketing authorization in usual clinical practice in Italy to evaluate efficacy and safety of DRV/r-based antiretroviral (ARV) treatment. This analysis focussed on the safety profile of DRV/r in HIV-1 infected patients.

Original language	English
Pages (from-to)	19573-19573
Number of pages	1
Journal	Journal of the International AIDS Society
Volume	17
DOIs	https://doi.org/10.7448/IAS.17.4.19573
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HIV
infected
naive

Access to Document

10.7448/IAS.17.4.19573

Cite this

@article{b77023e2b8b644d48136a0f3e69b07f0,

title = "Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -na{\"i}ve patients: analysis of data in the real-world setting in Italy",

abstract = "This descriptive, non-interventional study on HIV-1-infected patients treated with DRV/r in the usual clinical setting, with a single-arm prospective observational design, collected data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in marketing authorization in usual clinical practice in Italy to evaluate efficacy and safety of DRV/r-based antiretroviral (ARV) treatment. This analysis focussed on the safety profile of DRV/r in HIV-1 infected patients.",

keywords = "HIV, infected, naive, HIV, infected, naive",

author = "A Antinori and M Borderi and Roberto Cauda and T Bini and A Chirianni and N Squillace and D Mancusi and R. Termini",

year = "2014",

doi = "10.7448/IAS.17.4.19573",

language = "English",

volume = "17",

pages = "19573--19573",

journal = "Journal of the International AIDS Society",

issn = "1758-2652",

publisher = "John Wiley \& Sons Inc.",

}

TY - JOUR

T1 - Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy

AU - Antinori, A

AU - Borderi, M

AU - Cauda, Roberto

AU - Bini, T

AU - Chirianni, A

AU - Squillace, N

AU - Mancusi, D

AU - Termini, R.

PY - 2014

Y1 - 2014

N2 - This descriptive, non-interventional study on HIV-1-infected patients treated with DRV/r in the usual clinical setting, with a single-arm prospective observational design, collected data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in marketing authorization in usual clinical practice in Italy to evaluate efficacy and safety of DRV/r-based antiretroviral (ARV) treatment. This analysis focussed on the safety profile of DRV/r in HIV-1 infected patients.

AB - This descriptive, non-interventional study on HIV-1-infected patients treated with DRV/r in the usual clinical setting, with a single-arm prospective observational design, collected data on utilization of darunavir/ritonavir (DRV/r) under the conditions described in marketing authorization in usual clinical practice in Italy to evaluate efficacy and safety of DRV/r-based antiretroviral (ARV) treatment. This analysis focussed on the safety profile of DRV/r in HIV-1 infected patients.

KW - HIV

KW - infected

KW - naive

KW - HIV

KW - infected

KW - naive

UR - http://hdl.handle.net/10807/61167

U2 - 10.7448/IAS.17.4.19573

DO - 10.7448/IAS.17.4.19573

M3 - Article

SN - 1758-2652

VL - 17

SP - 19573

EP - 19573

JO - Journal of the International AIDS Society

JF - Journal of the International AIDS Society

ER -

Safety of darunavir/ritonavir (DRV/r) in HIV-1-infected DRV/r-experienced and -naïve patients: analysis of data in the real-world setting in Italy

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this